Dr Harrison discusses key takeaways for gastroenterologists and hepatologists about the management of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Dr Harrison highlights the importance of new treatment options for patients with nonalcoholic steatohepatitis, discusses findings from the REGENERATE clinical trial presented at the ACG 2019 Annual Meeting,...
